J
Joachim Frey
Researcher at University of Bern
Publications - 353
Citations - 14585
Joachim Frey is an academic researcher from University of Bern. The author has contributed to research in topics: Actinobacillus pleuropneumoniae & Mycoplasma mycoides. The author has an hindex of 64, co-authored 348 publications receiving 13490 citations. Previous affiliations of Joachim Frey include University of Würzburg.
Papers
More filters
Journal ArticleDOI
Microarray-Based Detection of 90 Antibiotic Resistance Genes of Gram-Positive Bacteria
Vincent Perreten,Lorianne Vorlet-Fawer,Peter Slickers,Ralf Ehricht,Peter Kuhnert,Joachim Frey +5 more
TL;DR: The ArrayTube platform presents the advantage of rapidly screening bacteria for the presence of antibiotic resistance genes known in gram-positive bacteria, and has a large potential for applications in basic research, food safety, and surveillance programs for antimicrobial resistance.
Journal ArticleDOI
Disseminated and sustained HIV infection in CD34+ cord blood cell-transplanted Rag2-/-gamma c-/- mice.
Stefan Baenziger,Roxane Tussiwand,Erika Schlaepfer,Luca Mazzucchelli,Mathias Heikenwalder,Michael O. Kurrer,Silvia Behnke,Joachim Frey,Annette Oxenius,Helen Joller,Adriano Aguzzi,Markus G. Manz,Roberto F. Speck +12 more
TL;DR: This straightforward to generate and cost-effective in vivo model closely resembles HIV infection in man and therefore should be valuable to study virus-induced pathology and to rapidly evaluate new approaches aiming to prevent or treat HIV infection.
Journal ArticleDOI
Virulence in Actinobacillus pleuropneumoniae and RTX toxins
TL;DR: RTX toxins are pore-forming, cytolytic protein toxins that occur widely among pathogenic Gram-negative bacteria, which have led to the development of new diagnostic and epidemiological tools, as well as vaccines, that are useful for a broad variety of serotypes.
Journal ArticleDOI
Characterization of apxIVA, a new RTX determinant of Actinobacillus pleuropneumoniae.
Alain Schaller,Rolf Kuhn,Peter Kuhnert,Jacques Nicolet,Timothy J. Anderson,Janet I. Maclnnes,Ruud Philip Antoon Maria Segers,Joachim Frey +7 more
TL;DR: Although the precise role of this new RTX determinant in pathogenesis of porcine pleuropneumonia needs to be determined, apxIVA is the first in vivo induced toxin gene that has been described in A. pleuroPneumoniae and seems to be species-specific.
Journal ArticleDOI
Proposal of a new serovar of Actinobacillus pleuropneumoniae: serovar 15.
TL;DR: It is proposed that these isolates represent a new serovar of A. pleuropneumoniae--serovar 15--with HS143 being the reference strain for the new seravar.